TS Financial Group (TSFG)’s Checkpoint Therapeutics CKPT Stock Holding History

TS Financial Group (TSFG)’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$1K	–	816
2025 Q1	$1K	Hold	300	–	–	﹤0.01%	746
2024 Q4	$1K	Hold	300	–	–	﹤0.01%	691
2024 Q3	$1K	Hold	300	–	–	﹤0.01%	723
2024 Q2	$1K	Hold	300	–	–	﹤0.01%	712
2024 Q1	$1K	Hold	300	–	–	﹤0.01%	709
2023 Q4	$1K	Hold	300	–	–	﹤0.01%	781
2023 Q3	$1K	Hold	300	–	–	﹤0.01%	909
2023 Q2	$1K	Hold	300	–	–	﹤0.01%	897
2023 Q1	$1K	Hold	300	–	–	﹤0.01%	874
2022 Q4	$2K	Hold	300	–	–	﹤0.01%	798
2022 Q3	$3K	Hold	300	–	–	﹤0.01%	705
2022 Q2	$3K	Hold	300	–	–	﹤0.01%	711
2022 Q1	$5K	Hold	300	–	–	﹤0.01%	639
2021 Q4	$9K	Hold	300	–	–	﹤0.01%	574
2021 Q3	$10K	Hold	300	–	–	﹤0.01%	553
2021 Q2	$9K	Hold	300	–	–	﹤0.01%	564
2021 Q1	$9K	Buy	+300	New	+$10.1K	﹤0.01%	507

TS Financial Group (TSFG)'s CKPT Position: Q2 2025 in Review

TS Financial Group (TSFG) sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 300 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in CKPT in Q1 2021 and held it in 17 quarters. The position peaked at $10K in Q3 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

TS Financial Group (TSFG) reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
TS Financial Group (TSFG) sold 300 Checkpoint Therapeutics shares in Q2 2025, an estimated $1K.
TS Financial Group (TSFG) first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 17 quarters.
TS Financial Group (TSFG)'s Checkpoint Therapeutics position peaked at $10K in Q3 2021.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2025, filed 5 Aug 2025.